National and Kapodistrian University of Athens
Διερεύνηση της ερυθροποιητικής απάντησης στην υποξαιμία ατόμων με χρόνιες πνευμονοπάθειες
Abstract
dc:descriptionThe aim of this study is to investigate the erythropoietic response to hypoxemia in chronic pulmonary disease. The study includes three parts: 1. Macrocytosis is a common finding in patients with chronic obstructive pulmonary disease (COPD). The cause for the elevation of MCV in these patients remains elusive. In an attempt to determine the extent of macrocytosis in COPD patients and search for possible causative factors, we evaluated the hematologic parameters, F cell percentage, blood gases and serum Epo levels in 32 COPD clinically stable patients and 34 sex- and age-matched non-smoker healthy volunteers. An increased MCV was observed in almost half of the hypoxemic COPD cases (14/32 or 43.75%), while erythrocytosis developed to a lesser degree (37.5%). The erythropoietic response did not correlate with the severity of hypoxia. Moreover, no significant correlation was found between macrocytosis and hypoxemia or erythrocytosis and red cell size. In some cases the two phenomena occurred independently. The F cell percentage was significantly elevated in the COPD group (p<0.01) and was associated with MCV values (n=32, r=0.41, p<0.05). This finding supports the hypothesis we put forward to explain the macrocytosis often observed in COPD, i.e., that the acute erythropoietic stress occurring repeatedly in these patients as a result of the frequent exacerbations may lead to waves of release of relatively immature red cells from the marrow, including an increased number of F-cells, reflecting the recruitment of normally dormant BFU- E, which maintain the program for γ-chain synthesis. The fact that erythrocytosis and macrocytosis, both being triggered by hypoxemia, do not occur consistently in all COPD patients indicates that many other factors may also intervene. 2. Long treatment with theophylline is often followed by a reduction of Hb levels, which is usually ascribed to the antagonistic activity between theophylline and adenosine (ADO) which leads to decreased Epo synthesis. This view is not unanimously accepted and several alternative explanations have been proposed. To evaluate the influence of theophylline on erythropoiesis in COPD we evaluated the hematologic parameters and Epo values in 32 patients with this condition. Twelve of them had been treated with theophylline (8mg/kg, daily) for at least 1 year; the other 20 patients had never received this drug. The severity of respiratory insufficiency was almost comparable in the 2 groups. A group of 34 sex- and age-matched healthy volunteers served as controls. Our findings failed to show any significant difference of the Hb and serum Epo values between the 2 COPD groups (treated and untreated). To further explore the underlying mechanisms, we studied the development of BFU-E-derived colonies in semisolid methylcellulose cultures in blood samples from 7 patients randomly selected from the above two groups. In addition, we studied the effects of theophylline on the erythroid cell development by adding this agent in erythroid cell cultures from 6 healthy volunteers at concentrations varying from 10-8 to 10-3 M. Our observations are summarized in that the serum of the theophylline- treated patients produced a significant inhibition of the growth of erythroid bursts in contrast to that of untreated patients and controls; this inhibition was concentration dependent. The fact that the Epo amount was consistently more than adequate for maximal erythropoietic development in all culture dishes, supports the hypothesis of a direct inhibitory action of theophylline on erythropoiesis, possibly through the enhanced apoptosis induced by this drug in several other types of cells. In spite of the clarity of these experiments, the influence of theophylline on the erythropoietic response of the COPD patients could not be proven, since the Hb levels did not show any significant differences. This controversy probably results from the intervention of other factors both on the serum levels of the drug and on the erythropoietic response of each individual marrow. 3. Idiopathic pulmonary fibrosis (IPF) is a chronic inflammatory process characterized by severe derangement of ventilation in the advanced stages of disease. However, erythrocytosis is considered infrequent in IPF. In an attempt to determine the potential relation between the blunted erythropoietic response and the chronic inflammation, we studied 9 patients (6 males and 3 females) suffering from IPF with severely affected respiratory function (PO₂ < 70mmHg) and 34 sex- and age-matched healthy volunteers. We evaluated the hematologic parameters, serum EPO, TNF-a, IL-6 and IL-8 levels. We further studied the development of BFU-E-derived colonies in semisolid methylcellulose cultures in blood samples from all patients. Hb and serum Epo levels were almost comparable between the 2 studied groups. On the contrary, serum TNF-a, IL-6, IL-8 values were significantly higher in patients with IPF (p<0.05, p<0.01, p<0.001 respectively). Serum of the patients induced a significant growth inhibition of erythroid bursts compared with that of controls (p<0.05, p<0.01). Moreover, there was an apparent increment in the number of BFU-e colonies when patients’ mononuclear cells were cultured in comparison with those of healthy subjects (p<0.05). Our findings suggest that in IPF there is an increased number of primitive erythroid progenitors, which fail to complete their proliferation and maturation in vivo. Cytokines released from alveolar macrophages seem to have not only local but also systemic effects, since the serum of these patients directly suppressed erythropoiesis. However, the in vivo decreased red blood cell production can not be entirely attributed to this suppression. Thus, we believe that there are many other factors in vivo acting either synergistically or additively, with final result the suboptimal erythropoietic response to hypoxia.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Tsantes, Argyrios
- Τσαντές, Αργύριος
Subjects
dc:subject × 16- Ερυθροποίηση
- Χρόνια αποφρακτική πνευμονοπάθεια (ΧΑΠ)
- Μακροκυττάρωση
- Ερυθροποιηικό στρες
- Ερυθροποιητίνη
- Κύτταρα F
- Erythropoiesis
- Chronic obstructive pulmonary disease (COPD)
- Macrocytosis
- Erythropoietic stress
- Erythropoietin
- F cells
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/22515